OKUR Stock Summary and Trading Ideas (Onkure Therapeutics - Class A | NASDAQ:OKUR)

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.

Onkure Therapeutics - Class A trades on the NASDAQ stock market under the symbol OKUR.

As of March 3, 2025, OKUR stock price declined to $4.83 with 22,394 million shares trading.

OKUR has a beta of 1.18, meaning it tends to be more sensitive to market movements. OKUR has a correlation of 0.04 to the broad based SPY ETF.

OKUR has a market cap of $64.43 million. This is considered a Micro Cap stock.

The top ETF exchange traded funds that OKUR belongs to (by Net Assets): VTI, VXF, IBB, IWC, AVSC.

OKUR support price is $4.76 and resistance is $5.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OKUR shares will trade within this expected range on the day.